Responses

Download PDFPDF

Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    High-dose of Fluticasone propionate in mild asthmatics

    Dear Editor

    In a study [1] by Ward et al the dose of fluticasone propionate used for mild asthmatics was several folds higher (1500 mcg) whereas the recommended dose in different International guidelines is only 200 mcg.The other flaws which need clarification are:
    a) Inhaled corticosteroid was withdrawn 3 months before putting the patients on this study; there is no mention of the number of puffs o...

    Show More
    Conflict of Interest:
    None declared.